This result is also consistent with the results of the in vitro experiments described above and suggests that inhibiting the elevated levels of phosphorylation of PI3K/AKT/NF-κB signaling is a potential therapeutic means for OPD to alleviate ALI. The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.